Loading clinical trials...
Loading clinical trials...
The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Guerbet
NCT04265053 · Cerebral Arterial Diseases
NCT06980064 · Coronary Stenosis, Cerebral Arterial Diseases, and more
NCT06067113 · Cerebral Arterial Diseases
NCT04364074 · Coronary Artery Disease, Hypertension, and more
Guerbet LLC
Bloomington, Indiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions